FMR LLC - INHIBIKASE THERAPEUTICS INC ownership

INHIBIKASE THERAPEUTICS INC's ticker is IKT and the CUSIP is 45719W106. A total of 20 filers reported holding INHIBIKASE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
FMR LLC ownership history of INHIBIKASE THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$394,000
+22.4%
433,3000.0%0.00%
Q2 2022$322,000
-49.8%
433,3000.0%0.00%
Q1 2022$641,000
+0.6%
433,3000.0%0.00%
Q4 2021$637,000
-22.6%
433,3000.0%0.00%
Q3 2021$823,000
-32.2%
433,3000.0%0.00%
Q2 2021$1,213,000
+101.8%
433,300
+333.3%
0.00%
Q1 2021$601,000
-12.9%
100,0000.0%0.00%
Q4 2020$690,000100,0000.00%
Other shareholders
INHIBIKASE THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Redmond Asset Management, LLC 125,805$62,9030.02%
Retirement Planning Co of New England, Inc. 35,212$17,6060.01%
CCG WEALTH MANAGEMENT, LLC 30,000$15,0000.01%
Koshinski Asset Management, Inc. 65,377$32,6880.00%
ZEKE CAPITAL ADVISORS, LLC 93,800$46,9000.00%
WELLS FARGO & COMPANY/MN 136$680.00%
NORTHERN TRUST CORP 28,872$14,4360.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 89,048$440.00%
STATE STREET CORP 121,000$60,5000.00%
View complete list of INHIBIKASE THERAPEUTICS INC shareholders